HKSE:01558 (China)
Â
Ordinary Shares - Class H
HK$
10.20
(+2.31%)
Aug 27
Business Description
Yichang HEC ChangJiang Pharmaceutical Co Ltd
ISIN : CNE1000023R6
Share Class Description:
HKSE:01558: Ordinary Shares - Class HCompare
Compare
Traded in other countries / regions
01558.Hong KongYIHCF.USA IPO Date
2015-12-29Description
Yichang HEC ChangJiang Pharmaceutical Co Ltd functions in the Chinese drug industry. As a domestic manufacturing wing of the HEC Group, Yichang employs its therapeutic technology to address viral, endocrine, metabolic, and cardiovascular diseases. The company's key revenue driver is the anti-viral product division, which manufactures its key product, Its products include Kewei, Ertongshu, Xinhaining, Oumeining and Xining.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.64 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.33 | |||||
Debt-to-EBITDA | 1.11 | |||||
Interest Coverage | 12.65 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.69 | |||||
Beneish M-Score | -1.54 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 45.9 | |||||
3-Year EBITDA Growth Rate | 32.2 | |||||
3-Year EPS without NRI Growth Rate | 119.8 | |||||
3-Year Book Growth Rate | 14.4 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.45 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.98 | |||||
9-Day RSI | 68.5 | |||||
14-Day RSI | 64.59 | |||||
6-1 Month Momentum % | -6.43 | |||||
12-1 Month Momentum % | 46.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.4 | |||||
Quick Ratio | 1.3 | |||||
Cash Ratio | 0.39 | |||||
Days Inventory | 100.79 | |||||
Days Sales Outstanding | 77.8 | |||||
Days Payable | 51.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 3.92 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.21 | |||||
Operating Margin % | 45.72 | |||||
Net Margin % | 31.66 | |||||
FCF Margin % | 17.13 | |||||
ROE % | 28.66 | |||||
ROA % | 15.6 | |||||
ROIC % | 22.22 | |||||
ROC (Joel Greenblatt) % | 42.24 | |||||
ROCE % | 30.32 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 4.13 | |||||
Forward PE Ratio | 4.33 | |||||
PE Ratio without NRI | 3.28 | |||||
Shiller PE Ratio | 12.29 | |||||
Price-to-Owner-Earnings | 169.99 | |||||
PS Ratio | 1.29 | |||||
PB Ratio | 1.03 | |||||
Price-to-Tangible-Book | 1.53 | |||||
Price-to-Free-Cash-Flow | 7.58 | |||||
Price-to-Operating-Cash-Flow | 4.9 | |||||
EV-to-EBIT | 3.83 | |||||
EV-to-EBITDA | 3.83 | |||||
EV-to-Revenue | 1.43 | |||||
EV-to-FCF | 8.27 | |||||
Price-to-Projected-FCF | 1.32 | |||||
Price-to-Graham-Number | 0.47 | |||||
Price-to-Net-Current-Asset-Value | 6.58 | |||||
Earnings Yield (Greenblatt) % | 26.11 | |||||
FCF Yield % | 13.14 | |||||
Forward Rate of Return (Yacktman) % | 19.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Yichang HEC ChangJiang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 6,884.89 | ||
EPS (TTM) (HK$) | 2.472 | ||
Beta | 1.03 | ||
Volatility % | 52.31 | ||
14-Day RSI | 64.59 | ||
14-Day ATR (HK$) | 0.261704 | ||
20-Day SMA (HK$) | 9.5315 | ||
12-1 Month Momentum % | 46.25 | ||
52-Week Range (HK$) | 6.13 - 13.3 | ||
Shares Outstanding (Mil) | 879.97 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Yichang HEC ChangJiang Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Yichang HEC ChangJiang Pharmaceutical Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Yichang HEC ChangJiang Pharmaceutical Co Ltd Frequently Asked Questions
What is Yichang HEC ChangJiang Pharmaceutical Co Ltd(HKSE:01558)'s stock price today?
The current price of HKSE:01558 is HK$10.20. The 52 week high of HKSE:01558 is HK$13.30 and 52 week low is HK$6.13.
When is next earnings date of Yichang HEC ChangJiang Pharmaceutical Co Ltd(HKSE:01558)?
The next earnings date of Yichang HEC ChangJiang Pharmaceutical Co Ltd(HKSE:01558) is .
Does Yichang HEC ChangJiang Pharmaceutical Co Ltd(HKSE:01558) pay dividends? If so, how much?
Yichang HEC ChangJiang Pharmaceutical Co Ltd(HKSE:01558) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |